Article Text

Download PDFPDF
Sequential therapy for Helicobacter pylori eradication: is levofloxacin better?
  1. A Zullo1,
  2. V De Francesco2,
  3. D Vaira3
  1. 1Gastroenterology and Digestive Endoscopy, ‘Nuovo Regina Margherita’ Hospital, Rome, Italy
  2. 2Gastroenterology Unit, ‘Riuniti’ Hospital, Foggia, Italy
  3. 3Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
  1. Correspondence to Dr Angelo Zullo, Gastroenterologia ed Endoscopia Digestiva, Ospedale Nuovo Regina Margherita, Via E Morosini, 30 00153, Roma; Italia; zullo66{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

We read with great interest the study by Romano et al on a modified sequential therapy regimen for Helicobacter pylori eradication.1 Basically, the trial showed that a novel levofloxacin-based regimen was more effective than the standard, clarithromycin-based sequential regimen, irrespective of levofloxacin dose used (250 mg or 500 mg twice daily). We thank the authors for seeking to improve the efficacy of sequential therapy. However, a note …

View Full Text


  • Competing interests None.

  • Provenance and peer review Not commissioned; not externally peer reviewed.

Linked Articles

  • PostScript
    Marco Romano Gerardo Nardone